DK3271374T3 - Peptid som binder specifikt til en a-beta-species til terapi og/eller diagnosticering af alzheimers demens - Google Patents

Peptid som binder specifikt til en a-beta-species til terapi og/eller diagnosticering af alzheimers demens Download PDF

Info

Publication number
DK3271374T3
DK3271374T3 DK16716456.5T DK16716456T DK3271374T3 DK 3271374 T3 DK3271374 T3 DK 3271374T3 DK 16716456 T DK16716456 T DK 16716456T DK 3271374 T3 DK3271374 T3 DK 3271374T3
Authority
DK
Denmark
Prior art keywords
demens
peptid
alzheimer
diagnosis
therapy
Prior art date
Application number
DK16716456.5T
Other languages
English (en)
Inventor
Dieter Willbold
Antonia Nicole Klein
Janine Kutzsche
Original Assignee
Priavoid Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Priavoid Gmbh filed Critical Priavoid Gmbh
Application granted granted Critical
Publication of DK3271374T3 publication Critical patent/DK3271374T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK16716456.5T 2015-03-20 2016-02-25 Peptid som binder specifikt til en a-beta-species til terapi og/eller diagnosticering af alzheimers demens DK3271374T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102015003676.9A DE102015003676A1 (de) 2015-03-20 2015-03-20 Spezifisch A-Beta Spezies bindende Peptide für die Therapie und/oder die Diagnose der Alzheimerschen Demenz
PCT/DE2016/000089 WO2016150415A1 (de) 2015-03-20 2016-02-25 Spezifisch a-beta-spezies bindende peptide für die therapie und/oder die diagnose der alzheimerschen demenz

Publications (1)

Publication Number Publication Date
DK3271374T3 true DK3271374T3 (da) 2020-09-07

Family

ID=55754031

Family Applications (1)

Application Number Title Priority Date Filing Date
DK16716456.5T DK3271374T3 (da) 2015-03-20 2016-02-25 Peptid som binder specifikt til en a-beta-species til terapi og/eller diagnosticering af alzheimers demens

Country Status (8)

Country Link
US (1) US10174097B2 (da)
EP (1) EP3271374B1 (da)
JP (1) JP6714610B2 (da)
CN (1) CN107428811B (da)
DE (1) DE102015003676A1 (da)
DK (1) DK3271374T3 (da)
ES (1) ES2815699T3 (da)
WO (1) WO2016150415A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102016125645A1 (de) * 2016-12-23 2018-06-28 Forschungszentrum Jülich GmbH D-enantiomere Peptide zur Therapie von chronischem und neuropathischem Schmerz
WO2020089912A1 (en) * 2018-11-01 2020-05-07 Technion Research & Development Foundation Limited Anti-biofilm compositions

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20020079731A (ko) * 1999-11-05 2002-10-19 액소닉스, 인코포레이티드. 아밀로이드, 아밀로이드-유사 침착물, 또는 β-쉬이트가풍부한 그의 병리학적 전구체로의 비정상적 단백질 폴딩과관련된 질환의 치료에 있어서 생체내에서 사용하기에적합한 펩티드 동족체 및 유사체
DE10117281A1 (de) * 2001-04-06 2002-10-24 Inst Molekulare Biotechnologie Peptid zur Diagnose und Therapie der Alzheimer-Demenz
CA2449990A1 (en) * 2001-06-22 2003-01-03 The University Of British Columbia Type 1 diabetes diagnostics and therapeutics
US7745569B2 (en) * 2003-04-07 2010-06-29 The Regents Of The University Of California Amyloid specific binding peptides and detecting abeta peptide
DE102005049537B4 (de) 2005-10-17 2010-04-22 Forschungszentrum Karlsruhe Gmbh Verfahren zur Herstellung zyklischer Peptide und Verwendung der derart hergestellten zyklischen Peptide
DE102008037564A1 (de) * 2008-11-19 2010-05-20 Forschungszentrum Jülich GmbH Zusammensetzung zur Herstellung von anti-Amyloid beta-Peptid-Antikörpern mit D-Peptiden
DE102012102998B4 (de) * 2012-04-05 2013-12-05 Forschungszentrum Jülich GmbH Polymere, enthaltend multivalente Amyloid-Beta-bindende D-Peptide und deren Verwendung
DE102012108598A1 (de) 2012-09-14 2014-04-10 Forschungszentrum Jülich GmbH Neue, von D3 abgeleitete D-enantiomere Peptide und deren Verwendung
JP2015518474A (ja) * 2012-04-05 2015-07-02 フォルシュングスツェントルム ユーリッヒ ゲゼルシャフト ミット ベシュレンクテル ハフツングＦｏｒｓｃｈｕｎｇｓｚｅｎｔｒｕｍ Ｊｕｅｌｉｃｈ ＧｍｂＨ 血液、血液生産物及び器官を処置する方法
DE102012022013A1 (de) 2012-11-02 2014-05-08 Forschungszentrum Jülich GmbH Fachbereich Patente Peptide, die an amino-terminal verkürztes Amyloid-beta-Peptid binden und deren Verwendung
DE102013016002A1 (de) * 2013-09-26 2015-03-26 Forschungszentrum Jülich GmbH Zyklische, Amyloid-Beta-bindende Peptide und deren Verwendung

Also Published As

Publication number Publication date
US20180044398A1 (en) 2018-02-15
WO2016150415A1 (de) 2016-09-29
US10174097B2 (en) 2019-01-08
DE102015003676A1 (de) 2016-09-22
CN107428811B (zh) 2021-08-24
JP2018512411A (ja) 2018-05-17
JP6714610B2 (ja) 2020-06-24
EP3271374A1 (de) 2018-01-24
ES2815699T3 (es) 2021-03-30
CN107428811A (zh) 2017-12-01
EP3271374B1 (de) 2020-06-03
WO2016150415A8 (de) 2020-03-19

Similar Documents

Publication Publication Date Title
DK3326641T3 (da) Rna-holdig sammensætning til behandling af tumorsygdomme
DK3331915T3 (da) Immun-checkpoint-inhibitorer til anvendelse til behandling af blodbårne cancere
DK3096798T3 (da) Plasmakallikreinbindende proteiner og anvendelser deraf til behandling af hereditært angioødem
DK3209691T3 (da) Sammensætninger til inducering af differentiering af myeloid-afledt suppresorcelle til behandling af cancer og infektiøse sygdomme
DK3119808T3 (da) Antistofsammensætninger til tumorbehandling
DK3377516T3 (da) Sammensætning til behandling af cancer
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3201336T3 (da) Fremgangsmåder til ekstrahering og oprensning af ikke-denaturerede proteiner
EA201691610A8 (ru) Анти-jagged1 антитела и способы применения
DK3197472T3 (da) Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri
DK3362066T3 (da) Kombinationsterapi til behandling af maligniteter
DK3524255T3 (da) Sammensætning til behandling af acne
DK3157531T3 (da) Fremgangsmåder og sammensætninger til stimulering af det intestinale enteroendokrinesystem til behandling af sygdomme eller tilstande relateret hertil
DK3127923T3 (da) Fremgangsmåde til forbedring af oppløselighed af protein og peptid ved hjælp af immunoglobulin-fc-fragment-binding
DK3209696T3 (da) Fremgangsmåder og sammensætninger til diagnosticering og behandling af glioblastom
MA53887A (fr) Anticorps à liaison protofibrille a-bêta améliorée
EA201890810A1 (ru) Соединения, эффективные для лечения гепатотоксичности и стеатоза печени, и их применение
DK3110446T3 (da) Fremgangsmåder og sammensætninger til behandling af Siglec-8-associerede sygdomme
DK3310190T3 (da) Sammensætning til behandling af kød og anvendelse af denne
DK3377094T3 (da) Virulenssvækkede bakterier til behandling af ondartede solide tumorer
DK3430143T3 (da) Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme
DK3468604T3 (da) Farmaceutiske kombinationer til behandling af cancer
DK3522873T3 (da) Sammensætninger og fremgangsmåder til behandlingen af xerostomi
DK3122743T3 (da) Sammensætninger og fremgangsmåder til behandling af neurodegenerative sygdomme